- Home
- IMCC vs ACON Comparison
IMCC vs ACON Comparison
Compare IMCC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- ACON
- Stock Information
- Founded
- IMCC 1980
- ACON 2008
- Country
- IMCC Israel
- ACON United States
- Employees
- IMCC N/A
- ACON N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- IMCC Health Care
- ACON Technology
- Exchange
- IMCC Nasdaq
- ACON Nasdaq
- Market Cap
- IMCC 7.5M
- ACON 7.1M
- IPO Year
- IMCC N/A
- ACON 2022
- Fundamental
- Price
- IMCC $1.58
- ACON $12.61
- Analyst Decision
- IMCC
- ACON Buy
- Analyst Count
- IMCC 0
- ACON 2
- Target Price
- IMCC N/A
- ACON $481.00
- AVG Volume (30 Days)
- IMCC 8.3K
- ACON 370.3K
- Earning Date
- IMCC 03-31-2025
- ACON 05-14-2025
- Dividend Yield
- IMCC N/A
- ACON N/A
- EPS Growth
- IMCC N/A
- ACON N/A
- EPS
- IMCC N/A
- ACON N/A
- Revenue
- IMCC $37,551,778.00
- ACON $49,289.00
- Revenue This Year
- IMCC $22.59
- ACON N/A
- Revenue Next Year
- IMCC $32.86
- ACON $186.36
- P/E Ratio
- IMCC N/A
- ACON N/A
- Revenue Growth
- IMCC 10.71
- ACON N/A
- 52 Week Low
- IMCC $1.50
- ACON $9.75
- 52 Week High
- IMCC $8.10
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- IMCC 36.99
- ACON 33.96
- Support Level
- IMCC $1.50
- ACON $9.75
- Resistance Level
- IMCC $1.84
- ACON $15.08
- Average True Range (ATR)
- IMCC 0.14
- ACON 3.14
- MACD
- IMCC -0.01
- ACON 12.50
- Stochastic Oscillator
- IMCC 16.33
- ACON 13.43
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.